Title CMTM8 induces caspase-dependent and -independent apoptosis through a mitochondria-mediated pathway
Authors Jin, Caining
Wang, Ying
Han, Wenling
Zhang, Yingmei
He, Qihua
Li, Dan
Yin, Caihua
Tian, Linjie
Liu, Dazhen
Song, Quanshen
Ma, Dalong
Affiliation Peking Univ, Sch Basic Med Sci, Lab Med Immunol, Beijing 100083, Peoples R China.
Peking Univ, Ctr Human Dis Genom, Beijing 100083, Peoples R China.
Peking Univ, Hlth & Med Anal Ctr, Beijing 100083, Peoples R China.
Peking Univ, Sch Basic Med Sci, Lab Med Immunol, 38 xueyuan Rd, Beijing 100083, Peoples R China.
Keywords GROWTH-FACTOR RECEPTOR
MONOCLONAL-ANTIBODY
TYROSINE KINASE
PANCREATIC-CANCER
CYTOCHROME-C
INDUCTION
INHIBITION
PROTEIN
CELLS
DEATH
Issue Date 2007
Publisher 细胞生理学杂志
Citation JOURNAL OF CELLULAR PHYSIOLOGY.2007,211,(1),112-120.
Abstract The mitochondria-mediated apoptotic pathway is regulated by members of the Bcl-2 family. Epidermal growth factor (EGF) induces Bad phosphorylation at Ser(112) via mitogen-activated protein kinase (MAPK), impairing its binding to Bcl-2 and Bcl-xL and interfering with their anti-apoptotic functions. In the current study, we utilized Western blot, immunofluorescence, flow cytometry, and confocal microscopy to examine the effects of CMTM8 overexpression on apoptosis. Our data indicated levels of Bad-S-112 phosphorylation were lower in CMTM8-transfected cells compared to pCDB-transfected cells. Caspase-dependent and independent mediated apoptosis, induced by CMTM8 overexpression, was facilitated by the mitochondria and inhibited by knockdown of Bad or overexpression of Bcl-xL. Previous research in our laboratory also demonstrated CMTM8 attenuated EGFR-mediated signaling pathways by decreasing ERK1/2phosphorylation levels. These data implicate CMTM8 as a negative regulator of EGF-induced signaling, with potential use as a novel therapeutic gene for EGFR-targeted anticancer gene therapy.
URI http://hdl.handle.net/20.500.11897/198568
ISSN 0021-9541
DOI 10.1002/jcp.20914
Indexed SCI(E)
PubMed
Appears in Collections: 基础医学院

Web of Science®


28

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.